Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9968737 | 1.00 | TSHR (0.57) | TSHRLMNAALDH1A1PTPN1BLM | |
| SCHEMBL11570599 | 0.97 | TSHR (0.55) | TSHRLMNAALDH1A1PTPN1BLM | |
| SCHEMBL6518338 | 0.97 | TSHR (0.55) | TSHRLMNAALDH1A1PTPN1BLM | |
| SCHEMBL1657135 | 0.94 | TSHR (0.57) | TSHRLMNAALDH1A1BLMTDP1 | |
| SCHEMBL6158415 | 0.92 | TSHR (0.55) | TSHRLMNAALDH1A1BLMTDP1 | |
| SCHEMBL3365945 | 0.92 | TSHR (0.55) | TSHRLMNAALDH1A1BLMTDP1 | |
| SCHEMBL6157463 | 0.92 | TSHR (0.55) | TSHRLMNAALDH1A1BLMTDP1 | |
| SCHEMBL3367058 | 0.92 | TSHR (0.55) | TSHRLMNAALDH1A1BLMTDP1 | |
| SCHEMBL10168047 | 0.88 | TSHR (0.63) | TSHRLMNAALDH1A1TDP1 | |
| SCHEMBL18638430 | 0.88 | TSHR (0.63) | TSHRLMNAALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020115729-A1 | Stabilization method and composition utilizing an amphoteric polymer | CONAGRA FOODS, INC. | 2002-08-22 | — | — | US | claimed |
| WO-2002041838-A2 | STABILIZATION METHOD AND COMPOSITION UTILIZING AN AMPHOTERIC POLYMER | CONAGRA FOODS, INC. (US) | 2002-05-30 | — | — | WO | claimed |
| EP-0395025-B1 | Attractant effective in relation to Tribolium Confusum J. | Japan Tobacco Inc. (JP) | 1993-09-15 | — | — | EP | claimed |
| US-5063058-A | Beetles | JAPAN TOBACCO INC. (JP) | 1991-11-05 | — | — | US | claimed |
| EP-0284363-B1 | 2, 6-DIMETHYL OCTYLFORMATE AND AN ATTRACTANT OF TRIBOLIUM CASTANEUM HERBST | Japan Tobacco Inc. (JP) | 1991-05-22 | — | — | EP | claimed |
| EP-0395025-A1 | Attractant effective in relation to Tribolium Confusum J. | Japan Tobacco Inc. (JP) | 1990-10-31 | — | — | EP | claimed |
| EP-0284363-A1 | 2, 6-dimethyl octylformate and an attractant of tribolium castaneum herbst | Japan Tobacco Inc. (JP) | 1988-09-28 | — | — | EP | claimed |
| JP-3047104-A | — | — | None | — | — | JP | disclosed |
| JP-63233942-A | — | — | None | — | — | JP | disclosed |
| EP-4746862-A2 | ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS | Aquestive Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-122075448-A | Pharmaceutical composition with enhanced permeation | — | 2026-05-26 | — | — | CN | disclosed |
| US-12622971-B2 | Linear polysaccharide based film products | AQUESTIVE THERAPEUTICS, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| WO-2026090119-A1 | PHARMACEUTICAL FILM STORAGE AND DISPENSER DEVICE | AQUESTIVE THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| JP-H0347104-A | LURING AGENT FOR TRIBOLIUM FERRUGINEUM FABRICIUS | JAPAN TOBACCO INC | 1991-02-28 | — | — | JP | disclosed |
| US-4970069-A | Method of attracting Tribolium castaneum Herbst with 2,6-dimethyl-octly formate | JAPAN TOBACCO, INC. (JP) | 1990-11-13 | — | — | US | disclosed |
| EP-0395025-A1 | Attractant effective in relation to Tribolium Confusum J. | Japan Tobacco Inc. (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0395025-A1 | Attractant effective in relation to Tribolium Confusum J. | Japan Tobacco Inc. (JP) | 1990-10-31 | — | — | EP | disclosed |
| JP-S63233942-A | 2,6-DIMETHYLOCTYL FORMATE AND ATTRACTANT FOR TRIBOLIUM CASTANEUM HERBST | JAPAN TOBACCO INC | 1988-09-29 | — | — | JP | disclosed |
| EP-0284363-A1 | 2, 6-dimethyl octylformate and an attractant of tribolium castaneum herbst | Japan Tobacco Inc. (JP) | 1988-09-28 | — | — | EP | disclosed |
| US-4100180-A | PLATINUM OXIDE CATALYST | TEIJIN, LIMITED (JP) | 1978-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622971-B2 | Linear polysaccharide based film products | SORD, SMCHD1, PLEC | TSHR 3406/4885LMNA 828/4885ALDH1A1 2294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.